From: The clinical impact of hepatitis C virus infection in Egyptian multiple myeloma patients
Items | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
HCV status | 0.741 | 0.462, 1.189 | 0.214 | 0.797 | 0.386, 1.645 | 0.540 |
Age (≥ 65 vs. < 65) | 1.545 | 0.553, 4.315 | 0.407 | 1.782 | 0.340, 9.337 | 0.494 |
Gender (male vs. female) | 1.003 | 0.613, 1.643 | 0.989 | 0.986 | 0.429, 2.262 | 0.973 |
ISS stage | 0.865 | 0.615, 1.214 | 0.406 | 1.367 | 0.558, 3.352 | 0.494 |
β2m (≥ 3.5 vs. < 3.5 mg/L) | 0.941 | 0.475, 1.863 | 0.861 | 0.329 | 0.057, 1.89 | 0.213 |
Albumin (< 3.5 vs ≥ 3.5 g/L) | 1.058 | 0.639, 1.749 | 0.827 | 1.282 | 0.504, 3.262 | 0.602 |
Hemoglobin (< 10 vs. ≥ 10 g/dL) | 0.592 | 0.361, 0.970 | 0.037* | 0.604 | 0.284, 1.287 | 0.191 |
Platelets (< 100 vs. ≥ 100 × 109/L) | 0.780 | 0.385, 1.579 | 0.490 | 0.784 | 0.072, 7.763 | 0.808 |
Serum calcium (≥ 12 vs. < 12 mg/dL) | 3.253 | 0.767, 13.795 | 0.110 | 7.042 | 1.12, 44.45 | 0.038* |
Serum creatinine (≥ 2.0 vs. < 2.0 mg/dL | 1.123 | 0.534, 2.362 | 0.760 | 0.741 | 0.162, 3.384 | 0.699 |
Serum ALT (abnormal vs. normal) | 0.973 | 0.236, 4.003 | 0.969 | -- | -- | -- |
Serum AST (abnormal vs. normal) | 1.055 | 0.545, 2.042 | 0.874 | 0.472 | 0.125, 1.782 | 0.268 |
Serum T. bil. (abnormal vs. normal) | 1.902 | 1.034, 3.50 | 0.039* | 10.94 | 2.92, 41.02 | < 0.001* |